BNC KOREA
VC Fund
Seoul, South Korea
BNC Korea is a research laboratory that creates strategic application products for biomarkets.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries BNC KOREA invests in
Stages BNC KOREA invests in
Countries BNC KOREA invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Choi Wan-kyu
|
|||
Investment Focus
Industry
- Biotechnology 2 (67%)
- Pharmaceutical 2 (67%)
- Medical 1 (33%)
- Biopharma 1 (33%)
Stage
- Series B 2 (67%)
- Series C 1 (33%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Choi Wan-kyu
CEO
|
CEO | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
GeneMedicine
|
GeneMedicine(GM) is a clinical stage biopharmaceutical company that focuses on developing next-generation viral immunotherapies, aiming to transform the therapeutic outcomes for cancer patients. Using their proprietary adenovirus platform, GM is developing several pipeline products that can be intratumorally and intravenously administered toselectively attack and eradicate tumor cells as well as potently stimulating multiple arms of antitumor immune response. GM’s viral immunotherapy has proven effective as both a standalone therapy and in combination with current standard of care, including immune checkpoint inhibitors (ICI). | Series C / May 20, 2025 | |
ProAbTech
|
ProAbTech develops biotechnology solutions focused on site-specific bioconjugation technology for therapeutic proteins and antibodies. Its platform enhances the precision, stability, and functionality of biologic drugs. The company works on advanced drug development solutions aimed at improving targeted therapies and supporting innovation inprotein-based pharmaceuticals and medical research applications. | $2.2M / Series B / Apr 03, 2024 | |
Mitoimmune Therapeutics
|
Mito Immune Therapeutics is a drug research and development biotech company. | $3.9M / Series B / Sep 21, 2023 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does BNC KOREA invest in?
BNC KOREA invests primarily in Biotechnology, Pharmaceutical and Medical startups, most often at Series B and Series C stage. Most of the 3 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact BNC KOREA?
Public channels for BNC KOREA include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at BNC KOREA?
The team at BNC KOREA includes Choi Wan-kyu (CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
